Semaglutide is given as a subcutaneous injection (under the skin)
External resources USP General Chapter 797: Pharmaceutical Compounding, Sterile Preparations Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides, PMC Factors Affecting Physical Stability of Peptide Therapeutics, Royal Society In case I do not see you, good afternoon, good evening, and good night
10.1038/cr.2008.3 55 XuS.-Y.WuY.-M.JiZ.GaoX.-Y.PanS.-Y
This stability and carrier-free effectiveness distinguish BPC-157 from other growth factor-based therapies that typically require complex delivery systems
It can be taken more easily and behaves more like a typical oral drug
Clinical outcomes and side effect profiles are bioequivalent, with the primary difference being cost and insurance barriers